Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'reboxetine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 73 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Raggi, MA; Bugamelli, F; Sabbioni, C; Ferranti, A; Fanali, S; Volterra, V
      Analysis of reboxetine, a novel antidepressant drug, in pharmaceutical tablets by capillary electrophoresis and derivative spectrophotometry

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    2. Willeit, M; Praschak-Rieder, N; Hilger, E; Neumeister, A; Kasper, S
      Reboxetine in a patient with seasonal bulimia resistant to SSRIs and lighttherapy

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    3. Hilger, E; Willeit, M; Praschak-Rieder, N; Stastny, J; Neumeister, A; Kasper, S
      Reboxetine in seasonal affective disorder: an open trial

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    4. Gutierrez, M; Abramowitz, W
      Lack of effect of a single dose of ketoconazole on the pharmacokinetics ofcitalopram

      PHARMACOTHERAPY
    5. Carboni, E; Spielewoy, C; Vacca, C; Nosten-Bertrand, M; Giros, B; Di Chiara, G
      Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene

      JOURNAL OF NEUROSCIENCE
    6. Schutz, G; Berk, M
      Reboxetine add on therapy to haloperidol in the treatment of schizophrenia: a preliminary double-blind randomized placebo-controlled study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    7. Ferri, M; Pozzi, G; Bolis, C; Jezzi, BG
      Sertraline and reboxetine association in depressive pseudodementia: Good cardiovascular effects

      ARCHIVES OF GERONTOLOGY AND GERIATRICS
    8. Manier, DH; Shelton, RC; Sulser, F
      Cross-talk between PKA and PKC in human fibroblasts: what are the pharmacotherapeutic implications?

      JOURNAL OF AFFECTIVE DISORDERS
    9. Keller, M
      Role of serotonin and noradrenaline in social dysfunction: a review of data on reboxetine and the Social Adaptation Self-evaluation Scale (SASS)

      GENERAL HOSPITAL PSYCHIATRY
    10. Spina, E; Avenoso, A; Scordo, MG; Ancione, M; Madia, A; Levita, A
      No effect of reboxetine on plasma concentrations of clozapine, risperidone, and their active metabolites

      THERAPEUTIC DRUG MONITORING
    11. Ohman, D; Norlander, B; Peterson, C; Bengtsson, F
      Bioanalysis of racemic reboxetine and its desethylated metabolite in a therapeutic drug monitoring setting using solid phase extraction and HPLC

      THERAPEUTIC DRUG MONITORING
    12. Mori, S; Popoli, M; Brunello, N; Racagni, G; Perez, J
      Effect of reboxetine treatment on brain cAMP- and calcium/calmodulin-dependent protein kinases

      NEUROPHARMACOLOGY
    13. Ficarra, R; Calabro, ML; Tommasini, S; Melardi, S; Cutroneo, P; Ficarra, P
      Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases

      CHROMATOGRAPHIA
    14. Invernizzi, RW; Parini, S; Sacchetti, G; Fracasso, C; Caccia, S; Annoni, K; Samanin, R
      Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex

      BRITISH JOURNAL OF PHARMACOLOGY
    15. Siepmann, M; Muck-Weymann, M; Joraschky, P; Kirch, W
      The effects of reboxetine on autonomic and cognitive functions in healthy volunteers

      PSYCHOPHARMACOLOGY
    16. Hendershot, PE; Fleishaker, JC; Lin, KM; Nuccio, ID; Poland, RE
      Pharmacokinetics of reboxetine in healthy volunteers with different ethnicdescents

      PSYCHOPHARMACOLOGY
    17. Penttila, J; Syvalahti, E; Hinkka, S; Kuusela, T; Scheinin, H
      The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system - A randomised placebo-controlled study on healthy volunteers

      PSYCHOPHARMACOLOGY
    18. Harkin, A; Morris, K; Kelly, JP; O'Donnell, JM; Leonard, BE
      Modulation of MK-801-induced behaviour by noradrenergic agents in mice

      PSYCHOPHARMACOLOGY
    19. Hennig, J; Lange, N; Haag, A; Rohrmann, S; Netter, P
      Reboxetine in a neuroendocrine challenge paradigm: evidence for high cortisol responses in healthy volunteers scoring high on subclinical depression

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    20. Hartter, S; Weigmann, H; Hiemke, C
      Automated determination of reboxetine by high-performance liquid chromatography with column-switching and ultraviolet detection

      JOURNAL OF CHROMATOGRAPHY B
    21. Versiani, M
      The selective noradrenaline re-uptake inhibitor reboxetine has an early onset of antidepressant action

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    22. Versiani, M
      Reboxetine, the first selective noradrenaline reuptake inhibitor antidepressant: Efficacy and tolerability in 2613 patients

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    23. Healy, D
      Emergence of antidepressant induced suicidality

      PRIMARY CARE PSYCHIATRY
    24. Scates, AC; Doraiswamy, PM
      Reboxetine: A selective norepinephrine reuptake inhibitor for the treatment of depression

      ANNALS OF PHARMACOTHERAPY
    25. Fleishaker, JC
      Pharmacokinetics and metabolism of reboxetine

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    26. Baldwin, DS; Buis, C; Carabal, E
      Tolerability and safety of reboxetine

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    27. Poggesi, I; Pellizzoni, C; Fleishaker, JC
      Pharmacokinetics of reboxetine in elderly patients with depressive disorders

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    28. Aguglia, E
      Reboxetine in the maintenance therapy of depressive disorder in the elderly: A long-term open study

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    29. Bergmann, JF; Laneury, JP; Duchene, P; Fleishaker, JC; Houin, G; Segrestaa, JM
      Pharmacokinetics of reboxetine in healthy, elderly volunteers

      EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    30. Fleishaker, JC
      Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression

      CLINICAL PHARMACOKINETICS
    31. Harkin, A; Nally, R; Kelly, JP; Leonard, BE
      Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta 1-adrenergic receptors in an animal model of depression

      JOURNAL OF NEURAL TRANSMISSION
    32. Malberg, JE; Eisch, AJ; Nestler, EJ; Duman, RS
      Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus

      JOURNAL OF NEUROSCIENCE
    33. Phillips, MA; Langley, RW; Bradshaw, CM; Szabadi, E
      The effects of some antidepressant drugs on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response inman

      JOURNAL OF PSYCHOPHARMACOLOGY
    34. El-Giamal, N; de Zwaan, M; Bailer, U; Lennkh, C; Schussler, P; Strnad, A; Kasper, S
      Reboxetine in the treatment of bulimia nervosa: a report of seven cases

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    35. Venditti, LN; Arcelus, A; Birnbaum, H; Greenberg, P; Barr, CE; Rowland, C; Williamson, T
      The impact of antidepressant use on social functioning: reboxetine versus fluoxetine

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    36. Wong, EHF; Sonders, MS; Amara, SG; Tinholt, PM; Piercey, MFP; Hoffmann, WP; Hyslop, DK; Franklin, S; Porsolt, RD; Bonsignori, A; Carfagna, N; McArthur, RA
      Reboxetine: A pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor

      BIOLOGICAL PSYCHIATRY
    37. Dencker, SJ
      The need for new and better antidepressants: reboxetine a new option

      ACTA PSYCHIATRICA SCANDINAVICA
    38. Eriksson, E
      Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin?

      ACTA PSYCHIATRICA SCANDINAVICA
    39. Humble, M
      Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy

      ACTA PSYCHIATRICA SCANDINAVICA
    40. Tanum, L
      Reboxetine: tolerability and safety profile in patients with major depression

      ACTA PSYCHIATRICA SCANDINAVICA
    41. Healy, D
      Reboxetine: its effects as measured by the social adaptation self-evaluation scale

      ACTA PSYCHIATRICA SCANDINAVICA
    42. Phillips, MA; Bitsios, P; Szabadi, E; Bradshaw, CM
      Comparison of the antidepressants reboxetine, fluvoxamine and amitriptyline upon spontaneous pupillary fluctuations in healthy human volunteers

      PSYCHOPHARMACOLOGY
    43. Holm, KJ; Spencer, CM
      Reboxetine - A review of its use in depression

      CNS DRUGS
    44. Singh, AN
      Concurrent electroconvulsive therapy in patients receiving reboxetine

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    45. Massana, J; Moller, HJ; Burrows, GD; Montenegro, RM
      Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    46. Montgomery, SA
      Predicting response: noradrenaline reuptake inhibition

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    47. Kasper, S
      From symptoms to social functioning: differential effects of antidepressant therapy

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    48. Katona, C; Bercoff, E; Chiu, E; Tack, P; Versiani, M; Woelk, H
      Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial

      JOURNAL OF AFFECTIVE DISORDERS
    49. Avenoso, A; Facciola, G; Scordo, MG; Spina, E
      No effect of the new antidepressant reboxetine on CYP2D6 activity in healthy volunteers

      THERAPEUTIC DRUG MONITORING
    50. Connor, TJ; Kelliher, P; Harkin, A; Kelly, JP; Leonard, BE
      Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat

      EUROPEAN JOURNAL OF PHARMACOLOGY
    51. Harkin, A; Kelly, JP; McNamara, M; Connor, TJ; Dredge, K; Redmond, A; Leonard, BE
      Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression

      EUROPEAN JOURNAL OF PHARMACOLOGY
    52. Sacchetti, G; Bernini, M; Bianchetti, A; Parini, S; Invernizzi, RW; Samanin, R
      Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain

      BRITISH JOURNAL OF PHARMACOLOGY
    53. Bitsios, P; Szabadi, E; Bradshaw, CM
      Comparison of the effects of venlafaxine, paroxetine and desipramine on the pupillary light reflex in man

      PSYCHOPHARMACOLOGY
    54. HERRMANN WM; FUDER H
      REBOXETINE, A SELECTIVE NORADRENALINE REUPTAKE INHIBITOR, IS NONSEDATIVE AND DOES NOT IMPAIR PSYCHOMOTOR PERFORMANCE IN HEALTHY-SUBJECTS

      Human psychopharmacology
    55. SZABADI E; BRADSHAW CM; BOSTON PF; LANGLEY RW
      THE HUMAN PHARMACOLOGY OF REBOXETINE

      Human psychopharmacology
    56. BRUNELLO N; RACAGNI G
      RATIONALE FOR THE DEVELOPMENT OF NORADRENALINE REUPTAKE INHIBITORS

      Human psychopharmacology
    57. HINDMARCH I
      EFFECT OF ANTIDEPRESSANTS ON COGNITIVE AND PSYCHOMOTOR FUNCTION - THELACK OF EFFECT OF REBOXETINE

      Human psychopharmacology
    58. BAN TA; GASZNER P; AGUGLIA E; BATISTA R; CASTILLO A; LIPCSEY A; MACHER JP; TORRESRUIZ A; VERGARA L
      CLINICAL EFFICACY OF REBOXETINE - A COMPARATIVE-STUDY WITH DESIPRAMINE, WITH METHODOLOGICAL CONSIDERATIONS

      Human psychopharmacology
    59. Healy, D; Healy, H
      The clinical pharmacologic profile of reboxetine: does it involve the putative neurobiological substrates of wellbeing?

      JOURNAL OF AFFECTIVE DISORDERS
    60. Walters, RR; Buist, SC
      Improved enantioselective method for the determination of the enantiomers of reboxetine in plasma by solid-phase extraction, chiral derivatization, and column-switching high-performance liquid chromatography with fluorescence detection

      JOURNAL OF CHROMATOGRAPHY A
    61. LEONARD BE
      NORADRENALINE IN BASIC MODELS OF DEPRESSION

      European neuropsychopharmacology
    62. HINDMARCH I
      THE EFFECTS OF ANTIDEPRESSANTS ON PSYCHOMOTOR FUNCTION WITH PARTICULAR REFERENCE TO REBOXETINE

      European neuropsychopharmacology
    63. DOSTERT P; BENEDETTI MS; POGGESI I
      REVIEW OF THE PHARMACOKINETICS AND METABOLISM OF REBOXETINE, A SELECTIVE NORADRENALINE REUPTAKE INHIBITOR

      European neuropsychopharmacology
    64. BERZEWSKI H; VANMOFFAERT M; GAGIANO CA
      EFFICACY AND TOLERABILITY OF REBOXETINE COMPARED WITH IMIPRAMINE IN ADOUBLE-BLIND-STUDY IN PATIENTS SUFFERING FROM MAJOR DEPRESSIVE EPISODES

      European neuropsychopharmacology
    65. FRIGERIO E; BENECCHI A; BRIANCESCHI G; PELLIZZONI C; POGGESI I; BENEDETTI MS; DOSTERT P
      PHARMACOKINETICS OF REBOXETINE ENANTIOMERS IN THE DOG

      Chirality
    66. WEISSMAN MM
      BEYOND SYMPTOMS - SOCIAL FUNCTIONING AND THE NEW ANTIDEPRESSANTS

      JOURNAL OF PSYCHOPHARMACOLOGY
    67. MONTGOMERY SA
      REBOXETINE - ADDITIONAL BENEFITS TO THE DEPRESSED PATIENT

      JOURNAL OF PSYCHOPHARMACOLOGY
    68. DUBINI A; BOSC M; POLIN V
      NORADRENALINE-SELECTIVE VERSUS SEROTONIN-SELECTIVE ANTIDEPRESSANT THERAPY - DIFFERENTIAL-EFFECTS ON SOCIAL FUNCTIONING

      JOURNAL OF PSYCHOPHARMACOLOGY
    69. HEALY D; MCMONAGLE T
      THE ENHANCEMENT OF SOCIAL FUNCTIONING AS A THERAPEUTIC PRINCIPLE IN THE MANAGEMENT OF DEPRESSION

      JOURNAL OF PSYCHOPHARMACOLOGY
    70. MUCCI M
      REBOXETINE - A REVIEW OF ANTIDEPRESSANT TOLERABILITY

      JOURNAL OF PSYCHOPHARMACOLOGY
    71. KERR JS; POWELL J; HINDMARCH I
      THE EFFECTS OF REBOXETINE AND AMITRIPTYLINE, WITH AND WITHOUT ALCOHOLON COGNITIVE FUNCTION AND PSYCHOMOTOR PERFORMANCE

      British journal of clinical pharmacology
    72. BENEDETTI MS; FRIGERIO E; TOCCHETI P; BRIANCESCHI G; CASTELLI MG; PELLIZZONI C; DOSTERT P
      STEREOSELECTIVE AND SPECIES-DEPENDENT KINETICS OF REBOXETINE IN MOUSEAND RAT

      Chirality
    73. THEOFILOPOULOS N; MCDADE G; SZABADI E; BRADSHAW CM
      EFFECTS OF REBOXETINE AND DESIPRAMINE ON THE KINETICS OF THE PUPILLARY LIGHT REFLEX

      British journal of clinical pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/02/20 alle ore 08:13:58